mRNA |
GSK-1904529A |
GDSC1000 |
pan-cancer |
AAC |
-0.077 |
0.02 |
mRNA |
RAF265 |
CTRPv2 |
pan-cancer |
AAC |
0.093 |
0.03 |
mRNA |
lenvatinib |
CTRPv2 |
pan-cancer |
AAC |
0.083 |
0.03 |
mRNA |
THZ-2-49 |
GDSC1000 |
pan-cancer |
AAC |
-0.067 |
0.03 |
mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.085 |
0.03 |
mRNA |
Rapamycin |
CTRPv2 |
pan-cancer |
AAC |
0.076 |
0.03 |
mRNA |
Mitomycin-C |
GDSC1000 |
pan-cancer |
AAC |
-0.078 |
0.03 |
mRNA |
17-AAG |
CCLE |
pan-cancer |
AAC |
0.1 |
0.03 |
mRNA |
Z-LLNle-CHO |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.03 |
mRNA |
piperlongumine:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.078 |
0.03 |